Search Results - "Tarpgaard, Line Schmidt"

Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies by Tarpgaard, Line Schmidt, Winther, Stine Brændegaard, Pfeiffer, Per

“…Systemic treatment of metastatic colorectal cancer (mCRC) has improved considerably over the past 20 years. First- and second-line combinations of 5FU,…”
Get full text

miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells by Rasmussen, Mads Heilskov, Lyskjær, Iben, Jersie-Christensen, Rosa Rakownikow, Tarpgaard, Line Schmidt, Primdal-Bengtson, Bjarke, Nielsen, Morten Muhlig, Pedersen, Jakob Skou, Hansen, Tine Plato, Hansen, Flemming, Olsen, Jesper Velgaard, Pfeiffer, Per, Ørntoft, Torben Falck, Andersen, Claus Lindbjerg

“…Oxaliplatin resistance in colorectal cancers (CRC) is a major medical problem, and predictive markers are urgently needed. Recently, miR-625-3p was reported as…”
Get full text

Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol by Justesen, Tobias Freyberg, Gögenur, Ismail, Tarpgaard, Line Schmidt, Pfeiffer, Per, Qvortrup, Camilla

“…Within the last two decades, major advances have been made in the surgical approach for patients with colorectal cancer. However, to this day we face…”
Get full text

Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) by Foslund, Ingrid Terese, von Magius, Sahra Aisha Vinholt, Ainsworth, Alan Patrick, Detlefsen, Sönke, Fristrup, Claus Wilki, Knudsen, Anja Oer, Mortensen, Michael Bau, Tarpgaard, Line Schmidt, Jochumsen, Kirsten Marie, Graversen, Martin

“…There are few data on Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in women with primary unresectable or…”
Get full text

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer by Palshof, Jesper Andreas, Høgdall, Estrid Vilma Solyom, Poulsen, Tim Svenstrup, Linnemann, Dorte, Jensen, Benny Vittrup, Pfeiffer, Per, Tarpgaard, Line Schmidt, Brünner, Nils, Stenvang, Jan, Yilmaz, Mette, Nielsen, Dorte Lisbet

“…No biomarker exists to guide the optimal choice of chemotherapy for patients with metastatic colorectal cancer. We examined the copy numbers (CN) of…”
Get full text

Short course immunotherapy as curative-intent treatment in stage I-III dMMR rectal cancer by Pfeiffer, Per, Andersen, Per Vadgaard, Salomon, Søren, Øgaard, Nadia, Demuth, Christina, Andersen, Claus Lindbjerg, Gögenur, Ismail, Justesen, Tobias Freyberg, de Lima, Vinicius Araujo, Tarpgaard, Line Schmidt

“…121 Background: Neoadjuvant chemo-radiation followed by resection is standard treatment for patients with locally advanced rectal cancer (RC). A subset of RC…”
Get full text

Plasma TIMP-1 in patients with metastatic colorectal cancer treated with first-line oxaliplatin-based therapy with or without cetuximab: Results from the Nordic VII study by Tarpgaard, Line Schmidt, Guren, Tormod Kyrre, Glimelius, Bengt, Sorbye, Halfdan, Ikdahl, Tone, Christensen, Ib Jarle, Qvortrup, Camilla, Kure, Elin, Pfeifer, Per, Nielsen, Hans J., Brünner, Nils

“…Abstract only e14710 Background: Plasma Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) is a biomarker in patients with metastatic colorectal cancer (mCRC)…”
Get full text

Benefit of EGFR-inhibition therapy for metastatic colorectal cancer patients with KRAS-mutated tumors and high plasma TIMP-1 level: Results from the NORDIC VII study by Brunner, Nils, Tarpgaard, Line Schmidt, Christensen, Ib Jarle, Moreira, Jose, Guren, Tormod Kyrre, Glimelius, Bengt, Sorby, Halfdan, Ikdahl, Tone, Kure, Elin, Tveit, Kjell Magne, Nielsen, Hans Jørgen, Pfeiffer, Per

“…Abstract only…”
Get full text

Benefit of EGFR-inhibition therapy for metastatic colorectal cancer patients with KRAS-mutated tumors and high plasma TIMP-I level: Results from the NORDIC VII study by Brunner, Nils, Tarpgaard, Line Schmidt, Christensen, Ib Jarle, Moreira, Jose, Guren, Tormod Kyrre, Glimelius, Bengt, Sorby, Halfdan, Ikdahl, Tone, Kure, Elin, Tveit, Kjell Magne, Nielsen, Hans Jorgen, Pfeiffer, Per

Get full text

Plasma concentrations of YKL-40 in chemo-naive patients with metastatic colorectal cancer treated with FLOX with or without cetuximab: Results from the NORDIC VII study by Tarpgaard, Line Schmidt, Guren, Tormod Kyrre, Glimelius, Bengt, Pfeiffer, Per, Kure, Elin, Yilmaz, Mette K. N., Sorbye, Halfdan, Keldsen, Nina, Skovlund, Eva, Johansen, Julia S., Tveit, Kjell Magne

“…Abstract only 3548 Background: KRAS status is presently the best biomarker to select patients with metastatic colorectal cancer (mCRC) for therapy with EGFR…”
Get full text

Plasma levels of TIMP-1 in chemo-naive patients with metastatic colorectal cancer treated with first-line FLOX with or without cetuximab: Results from the Nordic VII Study by Tarpgaard, Line Schmidt, Guren, Tormod Kyrre, Glimelius, Bengt, Sorbye, Halfdan, Ikdahl, Tone, Christensen, Ib Jarle, Qvortrup, Camilla, Kure, Elin, Pfeiffer, Per, Tveit, Kjell Magne, Nielsen, Hans J., Brünner, Nils

“…Abstract only 392 Background: KRAS status is presently the best known biomarker to select patients with metastatic colorectal cancer (mCRC) for therapy with…”
Get full text

Primary tumor location and expression of mir-664 as a combined biomarker for bevacizumab effectiveness in metastatic colorectal cancer by Boisen, Mogens Karsboel, Dehlendorff, Christian, Linnemann, Dorte, Larsen, Jim S., Oesterlind, Kell, Hansen, Joergen, Nielsen, Svend Erik, Pfeiffer, Per, Tarpgaard, Line Schmidt, Hollander, Niels Henrik, Keldsen, Nina, Hansen, Torben, Jensen, Brita Bjerregaard, Hoegdall, Estrid Vilma Solyom, Jensen, Benny Vittrup, Johansen, Julia S.

“…Abstract only 3572 Background: We aimed to identify tissue microRNAs (miRs) that could predict outcome for patients with metastatic colorectal cancer (mCRC)…”
Get full text